The engineering of CCR6, the receptor for CCL20, within epidermal growth factor receptor (EGFR)-targeting CAR-T cells led to improved trafficking, penetration, and clearance of solid tumors in a CCL20+ lung cancer xenograft mouse model [109]. This evidence concerns the gene CCL20 and lung cancer.